baber/WOPTO huggingface dataset:
Patent CA-2396526-A1 (CA)
Inventor: TASSES PAUL
IPC: A23L3/365
Filed: 2001-01-08
Abstract: A process for providing a home meal replacement as herein defined, comprising:  (i) providing a carrier tray for each meal of the home meal replacement to be served, (ii) introducing the meal into each carrier tray and subjecting the meal to conditions that inhibit microorganism growth and contamination of the meal, the meal consisting of one or more foods that are introduced into each carrier tray at desired positions to simulate a gourmet meal, (iii) freezing the meal in each carrier tray to a temperature that enables the meal to be cold stored until the meal is ready to be served, (iv) providing a serving dish for each carrier tray wherein the serving dish is of a size and shape that corresponds substantially to that of the carrier tray, (v) manipulating each carrier tray in such a way that the frozen meal therein is transferred into its respective serving dish, the meal being presented in its respective serving dish such that the one or more foods are located in the same relative positions as in the respective carrier tray, and (iv) heating or thawing the meal in each serving dish to edible temperature for serving and consumption.
Patent CA-2397061-A1 (CA)
Inventor: MAO OU
IPC: H01M4/36
Filed: 2001-01-03
Abstract: La présente invention concerne une composition pour électrode comprenant un matériau d'électrode constitué essentiellement d'au moins un métal élémentaire électrochimiquement inactif et d'au moins un métal élémentaire électrochimiquement actif sous forme d'un mélange amorphe à température ambiante. Le métal élémentaire électrochimiquement actif est de préférence l'aluminium, le silicium ou l'étain. Le mélange reste amorphe dans la mesure où la composition pour électrode est incorporée à un accumulateur électrique au lithium et se recycle totalement en un cycle complet de charge et décharge à température ambiante.
Patent CA-2398320-A1 (CA)
Inventor: HONG BUI
IPC: A63F3/00
Filed: 2002-08-15
Abstract: A method of playing a mini-Baccarat type game is disclosed.      The game is played using a playing surface and playing cards. Three cards are randomly dealt to each of a plurality of players and the dealer. The method includes multiple wager options, including the step of placement of a bet that the cumulative value of the three cards of one or more of the plurality of players will exceed the cumulative value of the three cards of the dealer. A game surface for playing the mini-Baccarat type game of the present invention is also disclosed.
Patent CA-2398754-A1 (CA)
Title: 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
Inventor: CUSACK KEVIN P
IPC: A61K31/53
Filed: 2001-02-06
Abstract: The present invention is directed to a compound of formula (I), racemic-diastereomeric mixtures thereof, optical isomers thereof, prodrugs thereof, isotopes thereof or pharmaceutically-acceptable salts of said compound, isomers, prodrugs and isotopes, wherein the variable are defined herein. The compounds of this invention are useful as inhibitors of serine/threonine and tyrosine kinases. In particular, compounds of this invention are useful as inhibitors of tyrosine kinases that are important in hyperproliferative diseases, especially in cancer and in the process of angiogenesis.
Patent CA-2401525-A1 (CA)
Inventor: SMITH ADRIAN LEONARD
IPC: A61P25/28
Filed: 2001-02-28
Abstract: Cette invention a trait à de nouveaux dérivés de l'urée correspondant à la formule I. Ces composés, qui sont des inhibiteurs de la gamma-sécrétase, s'avèrent, par le fait, des plus utiles en matière de prévention ou de traitement de la maladie d'Alzheimer.
Patent CA-2402742-A1 (CA)
Title: Method of treating or inhibiting colonic polyps
Inventor: DISCAFANI-MARRO CAROLYN M
IPC: A61K31/47
Filed: 2001-03-06
Abstract: This invention provides a method of treating or inhibiting colonic polyps which comprises providing a compound of formula (1); wherein R1, R2, R3, R4, X, Y, and n are defined hereinbefore, or a pharmaceutically acceptable salt thereof.
Patent CA-2403235-A1 (CA)
Title: Modulation of cytochrome p450 reductase activity
Inventor: WOLF C ROLAND
IPC: C12N9/02
Filed: 2002-09-13
Abstract: The use of a non-human transgenic animal having cells with a conditional deletion of cytochrome P450 reductase gene in product development, disposition or toxicity studies, or in rationalised product design or product discovery.
Patent CA-2404272-A1 (CA)
Inventor: DODGE FRANKLIN TIFFANY
IPC: A61B5/022
Filed: 2001-04-13
Abstract: Methods and systems reconstruct and verify aortic blood pressure waveforms from peripheral blood pressure waveform data using mathematical models. The models combine analytical models of pulse wave propagation in the cardiovascular system with empirical models derived from measurements taken from human subjects. When used to reconstruct the aortic pressure of a given subject, the models are adjusted to the subject and the subject's physiological state based upon measurements performed on the subject's cardiovascular system.
Patent CA-2404563-A1 (CA)
Title: Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
Inventor: CRAVCHIK ANIBAL
IPC: C12N5/10
Filed: 2001-03-27
Abstract: The present invention provides amino acid sequences of peptides that are encoded by genes within the Human genome, the GPCR peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the GPCR peptides and methods of identifying modulators of the GPCR peptides.
Patent CA-2408684-A1 (CA)
Inventor: ANDERSON LARRY
IPC: A01C9/08
Filed: 2001-06-11
Abstract: A potato seed planter (10) includes one or more planting units (40) with an endless conveyor. A plurality of cups (58) are attached to the conveyor and each cup (58) receives a potato seed as the conveyor travels upwardly between upper (52) and lower (50) sprockets. As the cups (58) pass around the upper sprocket (52), any extra seeds in cups (58) are removed by centrifugal force, differential velocity and/or a vibration unit (98). These extra potato seeds (8) are recycled and returned to the seed bowl (45). The cups (58) then travel through a generally horizontal singulation section (100) and around a third sprocket (54). The cups (58) are inverted as they pass around the third sprocket (54) and the seeds (8) fall onto the back surface of the next forwardly adjacent cup (58). A guide structure (110) holds the seeds (8) in the desired position until they reach a discharge area (112) where the individual seeds (8) are discharged into the furrow.
Patent CA-2408860-A1 (CA)
Title: Low gloss, textured powder coating
Inventor: NORRIS WILLIAM
IPC: C09D163/00
Filed: 2001-08-17
Abstract: A powder coating composition that includes at least about 9% by weight, based on total vehicle weight, of a branched carboxylic acid-functional polyester having a number average molecular weight of from about 425 to about 1050 and at least one vehicle component reactive with carboxylic acid groups produces a matte, textured coating.
Patent CA-2409687-A1 (CA)
Title: Molecular melt comprising a coupling agent and an antioxidant and methods for making and using the molecular melt
Inventor: SORENSON MARIUS W
IPC: C08J3/22
Filed: 2001-05-04
Abstract: The present invention includes a molecular melt composition comprising an antioxidant and a coupling agent. The molecular melt is partially amorphous in nature. The invention also includes a method for making the molecular melt composition and a method for using the molecular melt to produce coupled polymers. The invention further includes a method for using an antioxidant to phlagmatize a coupling agent.
Patent CA-2412581-A1 (CA)
Inventor: IVERSEN PATRICK L
IPC: A61K35/12
Filed: 2001-07-06
Abstract: L'invention concerne des compositions de cellules souches pluripotentielles traitées à l'aide d'un agent de blocage du TGF-.szlig. et les procédés utilisant lesdites compositions. Les cellules souches traitées à l'aide d'un agent de blocage du TGF-.szlig., qui sont viables sur une longue période de temps en culture, sans réplication ni différenciation, sont capables, dès leur transfert dans des conditions appropriées, de reconstitution hématopoïétique à long terme.
Patent CA-2413781-A1 (CA)
Inventor: MITCHELL DAVID
IPC: B05B12/06
Filed: 2001-06-26
Abstract: L'invention concerne un appareil de distribution de liquide comprenant : (i) un récipient (5) dans lequel le liquide peut être introduit à travers un entrée (1) en vue remplir partiellement le récipient et de mettre sous pression le liquide et l'air qui remplit le reste du récipient, (ii) une sortie (a) à travers laquelle le liquide peut être distribué à partir du récipient sous la pression du liquide et de l'air dans ledit récipient, (iii) une vanne entre le récipient et la sortie destinée à commander le passage du liquide du récipient à la sortie, (iv) un mécanisme de commande de vanne destiné à commander l'actionnement de la vanne en réponse à la pression du liquide et de l'air dans le récipient, et (v) des moyens (6, 7, 12, 14, 15) destinés à transmettre la pression du liquide et de l'air se trouvant dans le récipient au mécanisme de commande de vanne. Ce mécanisme comprend un élément mobile qui est actionné par la pression du liquide et de l'air se trouvant dans le récipient et qui actionne la vanne, l'élément de fermeture de la vanne pouvant être ouvert lorsque la pression du liquide et de l'air dans le récipient atteind un niveau prédéterminé.
Patent CA-2414146-A1 (CA)
Title: Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
Inventor: HEDLUND GUNNAR
IPC: A61K31/167
Filed: 2001-07-03
Abstract: This invention relates to the use of compounds of general formula (I) wherein, R is selected from methyl, ethyl, n-propyl, iso-propyl, c-propyl, n-butyl, sec.-butyl, iso-butyl, tert.-butyl, c-butyl, n-pentyl, sec.-pentyl, iso-pentyl, tert.pentyl, neo-pentyl, c-pentyl, c-hexyl and c-heptyl; RNa and RNb are the same or different and selected from hydrogen, methyl and ethyl; R2, R3, R5 and R6 are independently selected from hydrogen, methyl, methoxy, thiomethyl, hydroxy, fluoro, chloro, bromo, trifluoromethyl, phenyl and benzyl; n is 1, 2 or 3; R' and R'' are the same or different and selected from methyl, ethyl, n-propyl, iso-propyl,n-butyl, sec.-butyl, and iso-butyl or R' and R'' together form a saturated heterocyclic ring of 5-7 atoms is 1, 2, 3;  and pharmaceutically acceptable salts, hydrates and solvates thereof; for the preparation of a medicament for stimulation of transcription factor AP  (activator protein)-1; compositions comprising the compounds of formula (I).  The invention also comprises the compounds of general formula (I) with the exclusion of compounds wherein R, R' and R'' simultaneously are methyl. The compounds are useful for the treatment of cancer, infection and manic-depressive illness.
Patent CA-2416053-A1 (CA)
Inventor: HALL H TRACY JR
IPC: E21B47/12
Filed: 2001-07-18
Abstract: The invention is a system (11) for transmitting data through a string of down-hole components. In accordance with one aspect of the invention, the system (11) includes a plurality of down-hole components, such as sections of pipe in a drill string. Each down-hole component includes a pin end (13) and a box end (7), with the pin end (13) of one down-hole component being adapted to be connected to the box end (17) of the other. Each pin end (13) includes external threads (15) and an internal pin face distal to the external threads (15). Each box end (17) includes an internal shoulder face with internal threads (18) distal to the internal shoulder face. The internal pin face and the internal shoulder face are aligned with and proximate each other when the pin end (13) of one component is threaded into a box end (17) of the other component. The system also includes a first communication element located within a first recess formed in each internal pin face and a second communication element located within a second recess formed in each internal shoulder face.  Preferably, the first and second communication elements are inductive coils. Most preferably, the inductive coils each lie within a magnetically conductive, electrically insulating element, which take the form of a U-shaped trough. The system (11) also includes a conductor in communication with and running between each first and second communication element in each component.
Patent CA-2418115-A1 (CA)
Title: Imidazole derivatives
Inventor: SEYMOUR PATRICIA ANN
IPC: A61P21/06
Filed: 2001-07-25
Abstract: The invention provides compounds of formula (1), wherein R1, R2, R3, and R4 are as defined, and their pharmaceutically acceptable salts. Compounds of formula (1) are indicated to have activity inhibiting cdk5, cdk2, and GSK-3.  Pharmaceutical compositions and methods comprising compounds of formula (1) for treating and preventing diseases and conditions comprising abnormal cell growth, such as cancer, and neurodegenerative diseases and conditions and those affected by dopamine neurotransmission. Also described are pharmaceutical compositions and methods comprising compounds of formula (1) for treating male fertility and sperm motility; diabetes mellitus; impaired glucose tolerance; metabolic syndrome or syndrome X; polycystic ovary syndrome; adipogenesis and obesity; myogenesis and frailty, for example age-related decline in physical performance; acute sarcopenia, for example muscle atrophy and/or cachexia associated with burns, bed rest, limb immobilization, or major thoracic, abdominal, and/or orthopedic surgery; sepsis; hair loss, hair thinning, and balding; and immunodeficiency.
Patent CA-2421912-A1 (CA)
Title: Proteines transporteuses humaines isolees, molecules d'acide nucleique codant lesdites proteines, et utilisation desdites proteines
Inventor: BEASLEY ELLEN
IPC: C12P21/02
Filed: 2001-09-12
Abstract: L'invention concerne des séquences aminoacides peptidiques codées par des gènes du génome humain, les peptides transporteurs selon l'invention, laquelle concerne plus particulièrement des molécules de peptide et d'acide nucléique isolées, des procédés d'identification d'orthologues et de paralogues des peptides transporteurs, ainsi que de modulateurs desdits peptides transporteurs.
Patent CA-2422214-A1 (CA)
Title: Factor vii glycoforms
Inventor: KLAUSEN NIELS KRISTIAN
IPC: C12N15/12
Filed: 2001-10-02
Abstract: The present invention relates to compositions comprising Factor VII and other blood clotting factors having altered patterns of asparagine-linked glycosylation.
Patent CA-2423591-A1 (CA)
Inventor: SCHAFER-SINDLINGER ADOLF
IPC: B01D53/94
Filed: 2001-09-25
Abstract: L'invention concerne un procédé de réduction des quantités de monoxyde de carbone, d'hydrocarbures et de particules de suie dans les gaz d'échappement pauvres provenant d'un moteur à combustion interne utilisant un filtre à particules. Les particules de suie possèdent une température d'allumage des particules de suie T¿z? et le filtre à particules est régénéré de temps à autre en élevant la température de celui-ci au-dessus de la température d'allumage des particules de suie et en consumant ces dernières. La température du filtre à particules est élevée à la température requise pour lancer l'allumage des particules de suie en consumant plus de combustible sur le revêtement catalytique lorsque la surpression du gaz d'échappement atteint une valeur prédéterminée. Selon ce procédé, le filtre à particules possède un revêtement catalytique comprenant un premier groupe de composants permettant de réduire la température d'allumage des particules de suie, ledit premier groupe de composants contient au moins un composant de stockage d'oxygène et au moins un métal du groupe platine sélectionné à partir du groupe composé de platine, palladium et rhodium. Selon un mode de réalisation favori du procédé, le revêtement catalytique comprend également un second groupe de composants permettant d'oxyder le monoxyde de carbone et les hydrocarbures, ledit second groupe de composants comprenant au moins un matériau de support sélectionné dans le groupe composé d'oxyde d'aluminium, d'oxyde de silicium, d'oxyde de titanium, d'oxyde de zirconium et de zéolite et d'au moins un métal du groupe platine sélectionné dans le groupe composé de platine, palladium et rhodium déposé sur lesdits matériaux de support.
Patent CA-2424753-A1 (CA)
Title: Procede et installation pour echanger de l'energie terrestre entre un corps terrestre et un echangeur d'energie, notamment pour produire du courant
Inventor: HILDEBRAND HANS
IPC: F04D13/10
Filed: 2001-10-17
Abstract: Selon l'invention, un échangeur d'énergie (2) est relié à un échangeur d'énergie terrestre (18) par l'intermédiaire d'une conduite d'amenée (10) et une conduite de retour (14) pour de l'eau en circulation. La conduite d'amenée (10) et la conduite de retour (14) sont pourvues chacune d'une soupape d'arrêt régulable (12, 16). Au moins un tuyau d'amenée (20) thermo-isolé est entouré, dans un trou de forage (22), par un tuyau de séparation (24) auquel est raccordé, radialement vers l'extérieur, une zone de retour (28) pour l'eau en circulation. Cette zone de retour (28) comprend au moins un tuyau de retour (30) communiquant avec la conduite de retour (14), ainsi qu'une matière de remplissage poreuse (38) et communique, au moins au niveau de la base du trou de forage (22) avec l'orifice d'entrée inférieur (46) du tube d'amenée (20) ou les orifices d'entrée inférieurs (46, 46a) des tubes d'amenée (20, 20a) par l'intermédiaire d'un ou plusieurs orifices de passage (44) situés dans le tuyau de séparation (24). Un dispositif à fluide de pression (50) commutable et de préférence une soupape d'évacuation (56) servant à évacuer l'eau en circulation du tube d'amenée (20) et par conséquent à déclencher la production de vapeur d'eau et le transport de cette dernière hors du corps terrestre sont raccordés à la conduite d'amenée (10) entre la soupape d'arrêt (12) et l'échangeur d'énergie (18).
Patent CA-2426402-A1 (CA)
Title: Methods and instruments for treating pseudoarthrosis
Inventor: MCKAY WILLIAM F
IPC: A61L27/00
Filed: 2001-10-24
Abstract: Methods, instruments, and kits for treating spinal pseudoarthrosis are provided. In one embodiment, a method includes delivering to a location of spinal pseudoarthrosis an effective amount of an osteoinductive composition that includes an injectible osteoinductive composition that includes an injectible osteoinductive composition in a pharmaceutically acceptable carrier. In other embodiments, cannulated drills 10, 10', 10'' and surgical instrument assemblies, 50, 50' including a drill and a syringe 60 and 60' wherein the syringe has a distal end that is matingly engaged to a proximal end of the drill are provided. The drill and other instruments, instrument assemblies, and kits formed therefrom may advantageously be used in a method for treating pseudoarthrosis.
Patent CA-2427367-A1 (CA)
Title: Systems and methods for securing video card output
Inventor: EVANS GLENN F
IPC: G06F21/24
Filed: 2003-05-01
Abstract: The various methods and systems described herein are directed to supplying a secure channel for software executing on a host computer. The methods and systems address and provide solutions for an attack model in which rogue software executing on the host computer attempts to inappropriately obtain or otherwise manipulate data. Some embodiments can provide pixel data that can be kept confidential (in that untrusted software applications cannot read the data off of the display screen). In addition, other embodiments can preserve the integrity of the pixel data by detecting whether the pixel data has been inappropriately manipulated. Various embodiments are based on a decryption engine that is located on a video card very late in the video processing chain such that programmatic access to decrypted pixel data is denied.
Patent CA-2427643-A1 (CA)
Title: Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
Inventor: GELBER COHAVA
IPC: A61K49/00
Filed: 2001-11-01
Abstract: The invention provides new monoclonal antibodies and binding fragments thereof which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells. The antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease and of patients having SCLC disease. The antibody-recognized SCLC-specific surface antigens can serve as targets for detecting, diagnosing, inhibiting or killing SCLC cells.
Patent CA-2428791-A1 (CA)
Title: Aqueous suspension of a cellulose ether, method for the production thereof, and a dry blend
Inventor: BOSTROM PETER
IPC: C08L1/26
Filed: 2001-11-30
Abstract: This invention relates to a suspension of a water-soluble, nonionic cellulose ether having a fairly low content of an electrolytic salt exhibiting a high stability and a low viscosity. The suspension having a pH-value of below 8.0, contains 10-30 % by weight of a water-soluble, nonionic cellulose ether, and 10-22 % by weight of an electrolytic salt, wherein the electrolytic salt contains a) 10-90 % by weight of a salt of polyphosphate having 3-12 phosphate groups, and b) 10-90 % by weight of a salt selected from the group consisting of ortophosphate, pyrophosphate, sulphate, carbonate and a mixture thereof.  The suspension is advantageously produced by adding a dry blend containing the water-soluble cellulose ether in cross-linked form and the electrolytic salt to water.
Patent CA-2429165-A1 (CA)
Title: Filler composition for soft tissue augmentation and reconstructive surgery
Inventor: CHAPUT CYRIL
IPC: A61L27/24
Filed: 2001-11-15
Abstract: The present invention relates to a filler composition for soft-tissue augmentation and reconstructive surgery comprising an effective amount of an  injectable thermo-gelling solution comprising 0.1 to 5.0 % by weight of chitosan or collagen or a derivative thereof; and 1.0 to 20 % by weight of a  salt of polyol or sugar selected from the group consisting of mono-phosphate  dibasic salt, mono-sulfate salt and a mono-carboxylic acid salt of polyol or  sugar. The solution is stable and turns into a gel within a tem-perature ran ge from 20 to 70 ~C. The gel has a cosmetically acceptable consistency for providing a mechanical support to surrounding soft tissues once injected therein. The composition can thus be used as filler for soft tissue augmentation and reconstructive surgery.
Patent CA-2430423-A1 (CA)
Title: Base of led
Inventor: YU SAN-HUA
IPC: H01L33/64
Filed: 2003-05-29
Abstract: A base of LED includes a negative pole seat and a positive pole seat. The negative pole seat is made of conductive material with a flat negative pole plate at a lower outer side thereof, an integral negative pole body at an inner side thereof, multiple upright negative pole seat grooves at two lateral sides thereof and a negative pole recess at the top thereof respectively. The positive pole seat also is made of conductive material with a flat positive pole plate at the lower outer side thereof, an integral positive pole body at the inner side thereof, multiple seat grooves extending upright from the bottom at two lateral sides thereof. A crystal grain is located at the negative pole recess and a connecting wire at both ends thereof joined to the positive pole seat and the crystal grain and the negative pole plate and the positive pole plate are adhered to circuit of a circuit board to form a close circuit.